Osako, T., Kurisaki-Arakawa, A., Dobashi, A., Togashi, Y., Baba, S., Shiozawa, S., Ishigame, H., Ishige, H., Ohno, S., Ishikawa, Y. and Takeuchi, K. Distinct clinicopathologic features and possible pathogenesis of localized ALK-positive histiocytosis of the breast.
Am. J. Surg. Pathol., in press (2021) |
| Isoyama, S., Mori, S., Sugiyama, D., Kojima, Y., Tada, Y., Shitara, K., Hinohara, K., Dan, S. and Nishikawa, H.
Cancer immunotherapy with PI3K and PD-1 dual-blockade via optimal modulation of T cell activation signal.
J. Immunother. Cancer, 9, (2021)
|
Miyata, K., Imai, Y., Hori, S., Nishio, M., Loo, T. M., Okada, R., Yang, L., Nakadai, T., Maruyama, R., Fujii, r., Ueda, K., Jiang, L., Zheng, H., Toyokuni, S., Sakata, T., Shirahige, K., Kojima, R., Nakayama, M., Oshima, M., Nagayama, S., Hara, E. and Takahashi, A. Pericentromeric noncoding RNA changes DNA binding of CTCF and inflammatory gene expression in senescence and cancer.
Proc. Natl. Acad. Sci. U. S. A., 118, e2025647118 (2021)
|
Iwao, Y., Okamoto, Y., Shirahama, H., Tsukahara, S. and Tomida, A. eIF4B enhances ATF4 expression and contributes to cellular adaptation to asparagine limitation in BRAF-mutated A375 melanoma.
Biochem. Biophys. Res. Commun., 573, 93-99 (2021) |
Tanaka, M. and Nakamura, T. Modeling fusion gene-associated sarcoma: Advantages for understanding sarcoma biology and pathology.
Pathol. Int., in press (2021) |
Yoshino, S., Tanaka, M., Sunami, Y., Takahara, T., Yamazaki, Y., Homme, M., Niibori-Nambu, A., Osato, M., Minami, T., Ishihara, K. and Nakamura, T. Trib1 promotes the development of acute myeloid leukemia in a Ts1Cje mouse model of Down syndrome.
Leukemia, in press |
| Otsuji, K., Sasaki, T., Tanabe, M. and Seto, Y.
Quantitative assessment of HER2 gene amplification of breast cancer using droplet digital PCR.
Pathol. Int., in press (2021)
|
| Mashima, T., Wakatsuki, T., Kawata, N., Jang, M. K., Nagamori, A., Yoshida, H., Nakamura, K., Migita, T., Seimiya, H. and Yamaguchi, K.
Neutralization of the induced VEGF-A potentiates the therapeutic effect of an anti-VEGFR2 antibody on gastric cancer in vivo.
Sci. Rep., in press (2021)
|
Takagi, S., Sasaki, Y., Koike, S., Takemoto, A., Seto, Y., Haraguchi, M., Ukaji, T., Kawaguchi, T., Sugawara, M., Saito, M., Funauchi, Y., Ae, K., Matsumoto, S., Fujita, N. and Katayama, R. Platelet-derived lysophosphatidic acid mediated LPAR1 activation as a therapeutic target for osteosarcoma metastasis.
Oncogene, in press (2021)
|
Seimiya, H., Nagasawa, K. and Shin-Ya, K. Chemical targeting of G-quadruplexes in telomeres and beyond for molecular cancer therapeutics.
J. Antibiot., in press (2021)
|
